Gemcitabine plus oxaliplatin vs 5‐fluorouracil plus cisplatin plus radiotherapy
All‐cause mortality at 1 year · people with advanced biliary tract carcinomas
It is very uncertain whether gemcitabine plus oxaliplatin changes all‐cause mortality at 1 year compared with 5‐fluorouracil plus cisplatin plus radiotherapy (very low certainty).
1 finding from 1 review
- Gemcitabine‐based chemotherapy for advanced biliary tract carcinomas 2018 · Cochrane Headline outcomes onlyRR 0.56 [0.21, 1.52]1 study · 34 participantsVery low